MedTrace Pharma A/S: Financial statements 2018
CVR: 36497661
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
MedTrace Pharma A/S (CVR 36497661) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -68,239 and a net result of DKK -1,236,840 compared with DKK -2,002,540 the year before. Equity in the 2018 report amounted to DKK 6,736,728. The solvency ratio was 26.7%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -68,239
- Profit/Loss
- DKK -1,236,840
- Equity
- DKK 6,736,728
- Total Assets
- DKK 25,216,362
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -68 t. | -1.2 mio. | 6.7 mio. | 5 |
| 2017 | - | -2.2 mio. | -2 mio. | 2.4 mio. | 5 |
| 2016 | - | 1.5 mio. | 1.2 mio. | 4.2 mio. | 4 |
| 2015 | - | -232.4 mio. | -245.5 mio. | 2.8 mia. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
On December 28, 2018, the company changed its name from MedTrace A/S to MedTrace Pharma A/S.
As of July 12, 2018, Jens Hesthaven Sørensen has joined the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2017. Gross profit came to DKK -2,166,821, and the net result was DKK -2,002,540.
As of January 29, 2018, Michael Frank has joined the board of directors of MedTrace Pharma A/S.
As of January 29, 2018, Lenna Maria Boe Broberg has left the board of directors of MedTrace Pharma A/S.
About MedTrace Pharma A/S
MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The board consists of Erik Anders Strömqvist (chair), Cesare Orlandi, Charlotte Vindfeldt and Claus Henrik Berner Møller. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 32 employees (2026). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.